drugset / Trial / NCT07069569
A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a randomized, open-label, multicenter phase II study to evaluate the efficacy and safety of AHB-137 injection in combination with other hepatitis B drugs in participants with HBeAg-negative CHB treated with NAs.
Timeline
- Start
- 2025-06-08
- Primary completion
- 2027-07-15
- Completion
- 2028-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AHB-137 | Antisense oligonucleotide | — | Other |
| Subject | Hepatitis B vaccine | Vaccine | — | — |
| Subject | Peg-IFN | Protein / enzyme biologic | — | — |